Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. - Wikidata - wikimedia - TriplyDB

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

http://www.wikidata.org/entity/Q40480198

about

Functional neuroimaging in Parkinson's disease PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.Neuroimaging in pre-motor Parkinson's disease Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.Neuroimaging: current role in detecting pre-motor Parkinson's disease.Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.Substantia nigra hyperechogenicity with LRRK2 G2019S mutations Olfactory loss in Parkinson's disease.Olfactory dysfunction in LRRK2 G2019S mutation carriers Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.The relationship between cerebral Alzheimer's disease pathology and odour identification in old age.Biomarkers in Parkinson's disease.Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's Disease Sleep and non-motor symptoms in Parkinson's disease.Classical Parkinson disease versus Parkinson complex--reflections against staging and in favour of heterogeneity.Role of homocysteine in the treatment of Parkinson's disease.Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients.Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.Olfactory dysfunction as a diagnostic marker for Parkinson's disease.DIMETER: a haptic master device for tremor diagnosis in neurodegenerative diseases.Imaging dopamine transporters in Parkinson's disease.Olfaction as a biomarker in Parkinson's disease.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.Biomarkers for trials of neuroprotection in Parkinson's disease.Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features.Dementia with Lewy bodies: early diagnostic challenges.What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Olfaction deterioration in cognitive disorders in the elderly.Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.Modern treatment in Parkinson's disease, a personal approach.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study.Prodromal non-motor symptoms of Parkinson's disease.

P2860

Q27013767-196B7C33-02FB-4912-BF87-2D69E26F107C Q30564071-21C33315-06EC-4BB8-B307-A86FAD605C41 Q30635471-8C173553-7286-4E74-A508-EEB6A3670BE2 Q33603777-54FA32AC-7FE2-437E-8B64-D55502A55B93 Q33632441-9876E3FB-A9E8-499A-A54C-4F0D3BD25BFB Q33676222-5D08DF06-ED51-428D-9A06-09F13B1D3EEE Q33731267-09ED794E-8CA5-48E8-A9C9-6447BA6FAC93 Q34100703-02C8186D-B265-4021-962A-D3E184AB6C2C Q34234625-FFD5269E-D934-4AE5-ADDF-29820DCAEA2A Q34463276-C90BB6D5-CDB3-48ED-80F7-B90EB65384BC Q34861140-DCB4BDE0-8806-45D4-8110-0442DC0F8B18 Q35028848-6C4C11AF-E63A-4509-9B9D-06B6A9370454 Q35119617-D2FC19EE-1B64-4DCD-AD20-E2A00E61545B Q35614156-818069B6-8670-42A0-8852-A3DFD7E7A998 Q36227293-9C92C121-0D4F-49EE-A338-264235D4B592 Q36511295-3EB17128-5F34-465A-9B31-83721F339BE5 Q36701655-800CBDDD-8056-4CB5-B01B-BDB37D334FC2 Q36725295-4FA42F8C-12D7-4623-90FB-EDE77CD7EF2C Q36861710-89D9BE82-A2F6-42E8-ABEB-D802CFDFC805 Q37174063-A997CEFA-0B53-47D6-A786-112410DD5BEE Q37466992-DB2A9E1A-72C6-4F66-A826-A4001B345F88 Q37507963-EE5A6888-418D-45C1-AE74-ADEB09531CBE Q37641997-791704BD-F5AD-46C8-B0C7-6FD81A01B310 Q37731026-416285EA-9C4E-4F1D-94CA-C31EC8799C1F Q37800096-51F6B0A0-4D9B-41E7-AE7C-ACB623DED408 Q37800097-26BED39E-7F3A-494C-BCB5-BE04DC3371EC Q37824440-FFB9B3C3-DE01-44A8-A91C-8BB669C9F6C2 Q37864239-BC11A324-81CE-486C-9F6B-03D4B5591C27 Q38003065-EBA98812-ECC2-4F27-A97B-A7E280324357 Q38029716-30BDDDFE-CA34-4A5C-A93B-AEE5E3CDFEA4 Q38038544-CB893661-92E5-418A-AC1F-0495742C313B Q38123748-F42FA212-F916-4DC9-A151-4C4945594729 Q38126115-BDCC8483-1202-4F91-87FB-B9EFB479BA44 Q38492560-967C08B1-758F-4A5E-B682-FD724A91046C Q38500010-DEA98BA9-AB19-4AD8-813F-670ADC343357 Q38501869-8CE88377-B7B5-45D5-AAA8-68961468653F Q38570529-064B2077-09BB-4E7A-A1D0-A0A85E626A66 Q38752945-3E59FCDD-26AF-4DB6-A396-F07A319EEA3F Q39989016-B2021FE1-3D71-4BFC-8CA1-4EACFCBAA4CE Q40247459-F88694F6-21A1-4D0C-A4A2-9DA58DF780D2

P2860

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

http://www.wikidata.org/entity/Q40480198

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Detection of presymptomatic Pa ...... cranial sonography, and SPECT.

@en

type

label

Detection of presymptomatic Pa ...... cranial sonography, and SPECT.

@en

prefLabel

Detection of presymptomatic Pa ...... cranial sonography, and SPECT.

@en

P1433

Q40480198-EEE8B948-A368-46A8-A398-BD285A0DB2BD

P1476

Q40480198-A5FFC8A8-F354-4DE0-A873-8F9210EFDB0C

P2093

Q40480198-30B5E45C-791E-4140-B8AE-40596C7104F2

Q40480198-625512A4-D701-4559-BE47-78DA978C6A9E

Q40480198-D24842D3-CE63-47C8-8EEC-0B494ABFE63A

Q40480198-FCBC27E2-E0B7-4939-8C49-FAE0DF373A15

Q40480198-FCF31972-B8BE-4122-9A5B-F8950D10F2E8

P2860

Q40480198-0F1A18E0-E85B-4563-AE3E-65DE478FA213

Q40480198-8CB94574-DD90-4666-8A18-E9DAF872E186

Q40480198-B79AE314-0875-4979-A29E-F8A75D889BF7

Q40480198-D6874C13-22E0-4B12-838D-9213CECA1301

Q40480198-E59481A9-3A05-4435-A946-ABE52A5398EC

Q40480198-F55AD56A-FE3A-41EF-8E00-E61E6D27CD69

P304

Q40480198-E4B24CC2-D0DE-4ED8-B9AF-FB77848B983F

P31

Q40480198-8143EF9A-7C6A-4EAC-8BF4-3BCEDE9F1523

P356

Q40480198-AFB0B267-0728-48EC-8404-2D0D85BA62E4

P407

Q40480198-58E1A98B-8CE1-441F-85B5-0F5ECAF73901

P433

Q40480198-6A7380D6-6255-4920-B25D-88F711E0E287

P478

Q40480198-115916A1-83E1-48B4-928C-17DFE12735AE

P50

Q40480198-80263225-5B22-49A8-9791-5A8573D04D53

Q40480198-AF9173BE-9CFB-475F-95F5-21DF8DD2927D

P577

Q40480198-34885967-9469-4633-B539-6189C306157F

P698

Q40480198-7697E3BF-86BB-4A69-AAB2-7DB7097BE319

P921

Q40480198-F1F7A567-5B71-4FF6-B98A-552369B1634E

P356

P1433

Movement Disorders

P1476

Detection of presymptomatic Pa ...... cranial sonography, and SPECT.

@en

P2093

Antje Mueller

http://www.w3.org/2001/XMLSchema#string

Joachim Kropp

http://www.w3.org/2001/XMLSchema#string

Johannes Frasnelli

http://www.w3.org/2001/XMLSchema#string

Katja Cormann

http://www.w3.org/2001/XMLSchema#string

Ulrike Sommer

http://www.w3.org/2001/XMLSchema#string

P2860

Is Parkinson's disease a primary olfactory disorder?

Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Does a long preclinical period occur in Parkinson's disease?

Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease.

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

Characteristics of olfactory disorders in relation to major causes of olfactory loss.

P304

1196-1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.20141

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Heinz Reichmann

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15390014

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease